Aquestive Therapeutic (AQST.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov6

Aquestive Therapeutic released FY2025 Q3 earnings on November 5 After-Market EST, actual revenue USD 12.81 M (forecast USD 12.94 M), actual EPS USD -0.14 (forecast USD -0.1325)

00:00

Aquestive Therapeutics released FY2025 9-month earnings on November 5 After-Market EST, actual revenue USD 31.53 M, actual EPS USD -0.5161

00:00

Oct29

Aquestive Therapeutic to Release FY2025 Q3 Earnings on November 5 After-Market (EST), Forecast Revenue USD 12.94 M, EPS USD -0.1325

00:49

Oct8

Aquestive Therapeutics Inc. Obtains New Patents for Anaphylm™

11:00

Sep4

Aquestive Therapeutics Inc Announces FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application

11:01

Aug11

Aquestive Therapeutic released FY2025 Semi-Annual earnings on August 11 After-Market EST, actual revenue USD 18.72 M, actual EPS USD -0.3744

23:00

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 12.81 M, Net Income -15.45 M, EPS -0.1396

Aug11

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 10 M, Net Income -13.55 M, EPS -0.1363

May12

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 8.72 M, Net Income -22.93 M, EPS -0.2401

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More